These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15044728)

  • 41. A secondary sialic acid binding site on influenza virus neuraminidase: fact or fiction?
    Lai JC; Garcia JM; Dyason JC; Böhm R; Madge PD; Rose FJ; Nicholls JM; Peiris JS; Haselhorst T; von Itzstein M
    Angew Chem Int Ed Engl; 2012 Feb; 51(9):2221-4. PubMed ID: 22281708
    [No Abstract]   [Full Text] [Related]  

  • 42. Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands.
    Wei DQ; Du QS; Sun H; Chou KC
    Biochem Biophys Res Commun; 2006 Jun; 344(3):1048-55. PubMed ID: 16647045
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discovery of novel inhibitors of Trypanosoma cruzi trans-sialidase from in silico screening.
    Neres J; Brewer ML; Ratier L; Botti H; Buschiazzo A; Edwards PN; Mortenson PN; Charlton MH; Alzari PM; Frasch AC; Bryce RA; Douglas KT
    Bioorg Med Chem Lett; 2009 Feb; 19(3):589-96. PubMed ID: 19144516
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Computational design of drug candidates for influenza A virus subtype H1N1 by inhibiting the viral neuraminidase-1 enzyme.
    Tambunan US; Parikesit AA; Dephinto Y; Sipahutar FR
    Acta Pharm; 2014 Jun; 64(2):157-72. PubMed ID: 24914717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel alpha- and beta-amino acid inhibitors of influenza virus neuraminidase.
    Kati WM; Montgomery D; Maring C; Stoll VS; Giranda V; Chen X; Laver WG; Kohlbrenner W; Norbeck DW
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2563-70. PubMed ID: 11502530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and evaluation of 4-O-alkylated 2-deoxy-2,3-didehydro-N-acetylneuraminic acid derivatives as inhibitors of human parainfluenza virus type-3 sialidase activity.
    Tindal DJ; Dyason JC; Thomson RJ; Suzuki T; Ueyama H; Kuwahara Y; Maki N; Suzuki Y; von Itzstein M
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1655-8. PubMed ID: 17236768
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potent Inhibitors against Newcastle Disease Virus Hemagglutinin-Neuraminidase.
    Rota P; La Rocca P; Piccoli M; Montefiori M; Cirillo F; Olsen L; Orioli M; Allevi P; Anastasia L
    ChemMedChem; 2018 Feb; 13(3):236-240. PubMed ID: 29231283
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combining crystallographic information and an aspherical-atom data bank in the evaluation of the electrostatic interaction energy in an enzyme-substrate complex: influenza neuraminidase inhibition.
    Dominiak PM; Volkov A; Dominiak AP; Jarzembska KN; Coppens P
    Acta Crystallogr D Biol Crystallogr; 2009 May; 65(Pt 5):485-99. PubMed ID: 19390154
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel linear polymers bearing thiosialosides as pendant-type epitopes for influenza neuraminidase inhibitors.
    Matsuoka K; Takita C; Koyama T; Miyamoto D; Yingsakmongkon S; Hidari KI; Jampangern W; Suzuki T; Suzuki Y; Hatano K; Terunuma D
    Bioorg Med Chem Lett; 2007 Jul; 17(14):3826-30. PubMed ID: 17524642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Binding pattern of the long acting neuraminidase inhibitor laninamivir towards influenza A subtypes H5N1 and pandemic H1N1.
    Meeprasert A; Khuntawee W; Kamlungsua K; Nunthaboot N; Rungrotmongkol T; Hannongbua S
    J Mol Graph Model; 2012 Sep; 38():148-54. PubMed ID: 23079644
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exploring the interactions of unsaturated glucuronides with influenza virus sialidase.
    Bhatt B; Böhm R; Kerry PS; Dyason JC; Russell RJ; Thomson RJ; von Itzstein M
    J Med Chem; 2012 Oct; 55(20):8963-8. PubMed ID: 23017008
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influenza virus neuraminidase: structure, antibodies, and inhibitors.
    Colman PM
    Protein Sci; 1994 Oct; 3(10):1687-96. PubMed ID: 7849585
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of human neuraminidase 3 (NEU3) by C9-triazole derivatives of 2,3-didehydro-N-acetyl-neuraminic acid.
    Zou Y; Albohy A; Sandbhor M; Cairo CW
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7529-33. PubMed ID: 21036040
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective binding of antiinfluenza drugs and their analogues to 'open' and 'closed' conformations of H5N1 neuraminidase.
    Wang P; Zhang JZ
    J Phys Chem B; 2010 Oct; 114(40):12958-64. PubMed ID: 20860351
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design.
    Chand P; Babu YS; Bantia S; Chu N; Cole LB; Kotian PL; Laver WG; Montgomery JA; Pathak VP; Petty SL; Shrout DP; Walsh DA; Walsh GM
    J Med Chem; 1997 Dec; 40(25):4030-52. PubMed ID: 9406595
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A sialidase mutant displaying trans-sialidase activity.
    Paris G; Ratier L; Amaya MF; Nguyen T; Alzari PM; Frasch AC
    J Mol Biol; 2005 Jan; 345(4):923-34. PubMed ID: 15588836
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple field three dimensional quantitative structure-activity relationship (MF-3D-QSAR).
    Du QS; Huang RB; Wei YT; Du LQ; Chou KC
    J Comput Chem; 2008 Jan; 29(2):211-9. PubMed ID: 17559075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 4-(Acetylamino)-3-hydroxy-5-nitrobenzoic acid.
    Jedrzejas MJ; Luo M; Singh S; Brouillette WJ; Air GM
    Acta Crystallogr C; 1995 Sep; 51 ( Pt 9)():1910-2. PubMed ID: 7576370
    [TBL] [Abstract][Full Text] [Related]  

  • 59. On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).
    Mitrasinovic PM
    Biophys Chem; 2009 Mar; 140(1-3):35-8. PubMed ID: 19117662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biotin-, fluorescein- and 'clickable' conjugates of phospha-oseltamivir as probes for the influenza virus which utilize selective binding to the neuraminidase.
    Stanley M; Martin SR; Birge M; Carbain B; Streicher H
    Org Biomol Chem; 2011 Aug; 9(16):5625-9. PubMed ID: 21720632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.